Navigation Links
Argos Confirms Improved RNA Amplification Protocol Enhances Quality of Antigen-Specific Immune Response
Date:5/8/2013

ponse was shown to correlate with good clinical outcomes, including improved overall survival.

The improved RNA amplification process is being used in Argos Therapeutics' ADAPT Phase 3 clinical study for AGS-003, the company's most advanced product candidate. To create AGS-003, RNA is isolated from a small tumor sample obtained from standard tumor removal surgery (nephrectomy), and dendritic cells are taken during a single leukapheresis procedure. The tumor RNA is used to "program" the dendritic cells with the entire disease-antigen repertoire to trigger an immune response against the patient's specific cancer. These antigen-loaded dendritic cells are formulated into a ready-to-use, intradermal injection.

For more information about AGS-003 and the ADAPT study, visit www.ADAPTkidneycancer.com.

About the Arcelis™ Technology Platform

Arcelis is a fully personalized, active immunotherapy technology that captures all antigens, including mutated and variant antigens that are specific to each patient's disease. It has been shown to overcome immunosuppression by producing a durable memory T-cell response without adjuvants that are associated with toxicity. The technology can be leveraged to manufacture personalized therapies for any cancer or infectious disease.

The Arcelis process integrates readily into many current treatment paradigms, using only a small tumor or blood sample and the patient's own dendritic cells, which are derived and optimized following a single leukapheresis procedure. The proprietary process uses RNA isolated from the patient sample to program the dendritic cells to target the entire disease-antigen repertoire. The activated, antigen-loaded dendritic cells are then formulated into the patient's plasma and administered as an intradermal injection to produce the desired patient-specific immune response.

Arcelis technology also overcomes many of the manufact
'/>"/>

SOURCE Argos Therapeutics Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Study Results Demonstrate Analytical Treatment Interruption to Assess Antiviral Activity of Argoss Arcelis™ Personalized Immunotherapy for Treatment of HIV Patients, AGS-004, Is Acceptable Strategy for At Least 16 Weeks
2. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
3. Collegium Announces Results of Chronic Pain Patient Survey - Confirms Significant Unmet Medical Need for a Differentiated, Abuse-Deterrent, Extended-Release Opioid
4. New CDC Study Confirms Effectiveness of UV-C Disinfection in Reducing Harmful Pathogens for Hospitals
5. Lilly Confirms Date and Conference Call for First-Quarter 2013 Financial Results Announcement
6. Perrigo Confirms First to File Patent Challenge for Generic Version of Testosterone Gel 1.62%
7. Perrigo Confirms FDA Approval For Testosterone Gel 1%
8. New Analysis Confirms Albumin Preserves Kidney Function and Improves Survival in Common Abdominal Infection of Liver Disease
9. Beth Israel Deaconess Medical Center, Harvard Medical School Study Confirms Cannabis Sciences Approach to Development of CS-TATI-1 to Inhibit Kaposi Sarcoma
10. Quest Diagnostics Confirms Investor Day on November 16
11. TUV Rheinland Confirms Apparent Fraud in Mislabeling of DRX Products Manufactured by HTRD and Excite Medical
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... NEW YORK, May 6, 2015 Delcath Systems, ... medical device company focused on oncology with an emphasis ... announces financial results for the three months ended March ... quarter and recent weeks include: , Achieved quarterly ... than 43% compared with the first quarter of 2014; ...
(Date:5/6/2015)... , May 6, 2015 CVS Health (NYSE: CVS ... Baltimore locations that sustained heavy fire damage during ... in Baltimore over the past week or ... is ahead," said CVS Health President and CEO Larry Merlo ... path to better health. There is no better way that we ...
(Date:5/6/2015)... Fibich, Leebron, Copeland, Briggs & Josephson is ... been reached to resolve lawsuits involving individuals who were ... - manufactured by Takeda Pharmaceuticals - has been associated ... of the firm,s attorneys were instrumental in the coordination ... Fibich - Founding Partner of Fibich, Leebron, Copeland, ...
Breaking Medicine Technology:Delcath Reports 2015 First Quarter Financial Results 2Delcath Reports 2015 First Quarter Financial Results 3Delcath Reports 2015 First Quarter Financial Results 4Delcath Reports 2015 First Quarter Financial Results 5Delcath Reports 2015 First Quarter Financial Results 6Delcath Reports 2015 First Quarter Financial Results 7Delcath Reports 2015 First Quarter Financial Results 8CVS Health Announces it Will Rebuild Baltimore CVS/pharmacy Locations 2Takeda Agrees to $2.4 Billion Settlement for Actos Bladder Cancer Lawsuits 2
... JERSEY CITY, N.J., May 2, 2011 Aoxing ... Pharma"), a specialty pharmaceutical company focusing on research, ... products, announced that its operating subsidiary in China, ... a patent by the State Intellectual Property Office ...
... International, Inc. (NYSE: VRX ) (TSX: VRX) today ... and Cephalon, Inc. (NASADQ: CEPH) on their announcement that Cephalon ... the news, Valeant has withdrawn its consent solicitation. ... Cephalon stockholders and we are pleased that Teva has paid ...
Cached Medicine Technology:Aoxing Pharmaceutical Company Announces Issuance of Chinese Patent for Naloxone Sublingual Film 2Aoxing Pharmaceutical Company Announces Issuance of Chinese Patent for Naloxone Sublingual Film 3Valeant Pharmaceuticals Congratulates Teva and Cephalon on Their Transaction 2
(Date:5/6/2015)... Springs, Texas (PRWEB) May 06, 2015 ... stages of the HIMSS EMR Adoption Model, the ... paper, improve patient engagement and automate processes. The ... transitioned from paper-driven to electronic workflows, patient registration ... hard copies of consents. With HIMSS Stage 7 ...
(Date:5/6/2015)... Experienced Vancouver air conditioning installation and repair company, ... now conduct their cooling services, including air conditioning repair ... and residential units. Strata complex air conditioning services are ... knowledge as well as a professionally trained staff. ... away any old air conditioning unit to be recycled, ...
(Date:5/6/2015)... Vancouver, BC (PRWEB) May 06, 2015 ... colon hydrotherapy supplier, is excited to announce a ... will help reduce the industry’s carbon footprint while ... These kits feature Eco-Flex™, the world’s ... “This is a game-changer for hydrotherapists,” claims the ...
(Date:5/6/2015)... May 06, 2015 Animals make just as ... are also good for your health. An Ohio veterinarian ... an increase he's seeing with health advantages of owning a ... When it comes to pet ownership, there are proven health ... Dr. Scott Leffler of the Animal Medical Center ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 Inversion ... specializes in yoga and Pilates classes, provides personalized ... and products, starting with its new Pilates Ring ... effort of becoming leaner, stronger, more centered and ... offer a fresh venue to healthy fitness through ...
Breaking Medicine News(10 mins):Health News:Access Electronic Patient Signatures Help Hilo Meet HIMSS Stage 7 Paperless Targets & Save $200,000 a Year on Consent Forms 2Health News:Access Electronic Patient Signatures Help Hilo Meet HIMSS Stage 7 Paperless Targets & Save $200,000 a Year on Consent Forms 3Health News:Pro Ace Care Now Does Air Conditioning Installation for Strata Complexes 2Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 2Health News:World’s First Compact Colon Hydrotherapy Speculum Kit 3Health News:Veterinarian Supports 2015 HABRI Study Citing Increase in Health Advantages of Pet Owners 2Health News:Veterinarian Supports 2015 HABRI Study Citing Increase in Health Advantages of Pet Owners 3Health News:Inversion Studios’ New Pilates Ring Is Circle of Magic for Body, Mind and Spirit 2Health News:Inversion Studios’ New Pilates Ring Is Circle of Magic for Body, Mind and Spirit 3
... renowned health,professionals are joining forces at the 2nd ... Conference, April 3-6, 2008 in,Taos, New Mexico. Research ... today,s most pertinent health issues including celiac disease, ... Based on extensive medical research, IHI has ...
... Mesa Laboratories,Inc. (Nasdaq: MLAB ) today reported significantly ... nine months ended December 31, 2007., Highlights:, ... net income increases 37% -- Third quarter diluted EPS ... net sales increased 13 percent to,$4,614,000 from $4,095,000 in the ...
... Unlike other epilepsy meds, Trileptal was no better than ... -- The epilepsy drug oxcarbazepine (Trileptal) does not seem ... finds. , Migraines affect more than 28 million Americans, ... effective in preventing these severe headaches. For this reason, ...
... among men not as low as should be , , MONDAY, ... the increase among American women, and the prevalence of this ... men is still not as low as it should be, ... than optimal is among the leading two or three risks ...
... Presented at Annual Meeting of the American Academy of ... ... NeoStrata today released new,clinical data that demonstrates significant benefits in ... at-home products in improving the appearance,and texture of facial skin. The ...
... February 11, 2008 Wiley-Blackwell, the scientific, technical, ... & Sons, Inc. (NYSE: JWa), (NYSE: JWb), today ... named the 2007 Best New Journal-Social Sciences & ... & Scholarly Publishing (PSP) Division. Each year, the ...
Cached Medicine News:Health News:Conference to Explore America's Health Challenges 2Health News:Mesa Labs Reports Higher Quarterly Sales and Earnings 2Health News:Mesa Labs Reports Higher Quarterly Sales and Earnings 3Health News:Mesa Labs Reports Higher Quarterly Sales and Earnings 4Health News:Mesa Labs Reports Higher Quarterly Sales and Earnings 5Health News:Epilepsy Drug Doesn't Prevent Migraines 2Health News:High Blood Pressure on Increase Among American Women 2Health News:NeoStrata Clinical Findings Reveal Benefits of Combining Glycolic Acid Peels and Targeted Home Care With Microdermabrasion for Optimized Treatment of Photodamaged Skin 2Health News:Mind, Brain, and Education is recognized as best new journal 2
BD Vacutainer® Specialty Tubes - Trace Element - Glass...
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
BD Vacutainer® Plus Plastic Serum Tubes have spray-coated silica and are used for serum determinations in chemistry, serology, and immunohematology....
BD Vacutainer® Heparin Tubes are spray-coated with either lithium heparin or sodium heparin and are used for plasma determinations in chemistry....
Medicine Products: